跳至主要内容
临床试验/JPRN-UMIN000000852
JPRN-UMIN000000852已完成2 期

Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells and natural killer T (NKT) cells in patients with operable recurrent head and neck cancer - Clinical study of alpha-GalactosylCeramide-pulsed dendritic cells and natural killer T (NKT) cells in patients with operable recurrent head and neck cancer

Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University0 个研究点目标入组 13 人开始时间: 2008年6月30日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
13

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who have: been treated with previous therapy of at least 4 weeks; uncontrolled diabetes mellitus, pulmonary fibrosis, and/or infection; a history of hepatitis; a positive response for hepatitis B surface antigen, or human immunodeficiency virus (HIV), hepatitis C virus, or human T-lymphotrophic virus antibodies; serious cardiac disease; recieived concurrent corticosteroid therapy; pregnancy or lactation; autoimmune diseases; been judged to be inappropriate to participate in this study by principle investigator or co-investigator

研究者

发起方
Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University

相似试验